Xilio Therapeutics, Inc. (XLO)
8.48
+0.07
(+0.83%)
USD |
NASDAQ |
Apr 01, 16:00
8.50
+0.02
(+0.24%)
After-Hours: 20:00
Xilio Therapeutics Total Assets (Quarterly) : 156.69M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Johnson & Johnson | 199.21B |
| Merck & Co., Inc. | 136.87B |
| Pfizer Inc. | 208.16B |
| Verastem, Inc. | 246.44M |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 121.42M |
| Shareholders Equity (Quarterly) | 35.27M |
| Debt to Equity Ratio | 0.1971 |
| Current Ratio | 2.577 |
| Net Debt Paydown Yield | 0.05% |